US Broker Ratings

Merus N.V. (MRUS) Stock Analysis: Exploring a 37% Upside in the Biotech Sector

The Netherlands-based Merus N.V. (NASDAQ: MRUS) is making waves in the biotechnology sector with its innovative approach to developing antibody therapeutics. As a clinical-stage immuno-oncology company,..

MannKind Corporation (MNKD): Analyst Ratings Highlight a Promising 130% Upside

MannKind Corporation (NASDAQ: MNKD), a notable player in the biotechnology sector, is capturing investor attention with its promising growth prospects and analyst ratings that suggest a..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Uncovering a Potential 314.93% Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Structure Therapeutics Inc. (NASDAQ: GPCR) presents a compelling case with a notable potential upside of 314.93%, based on..

Amneal Pharmaceuticals, Inc. (AMRX): Investor Outlook with a 43.82% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, is capturing the attention of investors with its promising growth potential. As a key..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Potential 87% Upside in the Precision Medicine Space

Investors with an eye for innovation in the healthcare sector should closely monitor IDEAYA Biosciences, Inc. (NASDAQ: IDYA). The precision medicine oncology company, with a market..

Beam Therapeutics Inc. (BEAM): Analyst Ratings Reveal 111% Potential Upside for Biotech Innovator

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in the field of precision genetic medicines, stands at the forefront of the biotechnology industry with its innovative approaches..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Evaluating a 27.97% Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a leading biopharmaceutical company specializing in the development of treatments for central nervous system (CNS) disorders and rare diseases, presents an..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Opportunities in the Dental Market

Envista Holdings Corporation (NYSE: NVST) stands as a significant player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. With a market capitalization..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Unpacking a 31.79% Potential Upside in Healthcare Investments

Guardian Pharmacy Services, Inc (GRDN) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

89bio, Inc. (ETNB) Investor Outlook: A Biotech Stock with a 208.91% Potential Upside

Investors seeking opportunities in the biotechnology sector may find 89bio, Inc. (ETNB) an intriguing prospect. With a market capitalization of $1.39 billion, this San Francisco-based clinical-stage..

Liquidia Corporation (LQDA) Stock Analysis: Navigating a 52.88% Potential Upside in the Biotech Sector

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology industry, has been making waves with its innovative approach to treating pulmonary diseases. With a market..

ARS Pharmaceuticals, Inc. (SPRY): A Biotech Gem with 74% Potential Upside

For investors seeking promising opportunities in the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) stands out with a compelling 74.39% potential upside, according to recent analyst..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A Promising 26.71% Upside in the Medical Instruments Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a distinguished player in the healthcare sector specializing in medical instruments and supplies, has been catching the eye of investors with..

Haemonetics Corporation (HAE) Stock Analysis: Navigating a 23.83% Potential Upside in the Medical Device Sector

Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity for investors in the dynamic healthcare sector. As a leading player in the medical devices industry, Haemonetics offers..

Amicus Therapeutics, Inc. (FOLD) Investor Outlook: Uncovering a 158% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) presents a captivating opportunity for investors, particularly those interested in the healthcare sector and the biotechnology industry. Headquartered in Princeton, New..

Premier, Inc. (PINC) Stock Analysis: Navigating the Healthcare Services Landscape with a 4% Dividend Yield

Premier, Inc. (NASDAQ: PINC) is a notable player in the healthcare information services sector, commanding a market capitalization of approximately $1.93 billion. As a healthcare improvement..

MoonLake Immunotherapeutics (MLTX): Analyst Consensus Reveals Significant 43.76% Potential Upside

MoonLake Immunotherapeutics (MLTX), a clinical-stage biotechnology company based in Switzerland, is capturing investor attention with its promising therapeutic developments in the field of inflammatory diseases. With..

Edgewise Therapeutics (EWTX): Unpacking a Potential 172% Stock Upside with Strong Analyst Confidence

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising contender in the biotechnology sector, is drawing investor attention with a potential upside of 172.22%, according to analyst consensus...

Travere Therapeutics, Inc. (TVTX) Investor Outlook: Exploring a 122% Upside Potential in Rare Disease Treatment

Travere Therapeutics, Inc. (TVTX) stands out in the biopharmaceutical landscape, focusing on developing therapies for rare kidney and metabolic diseases. With its headquarters in San Diego,..

Organon & Co. (OGN) Stock Analysis: Evaluating a 33% Potential Upside Amidst Healthcare Sector Challenges

Investors considering Organon & Co. (NYSE: OGN) are looking at a company that, despite its challenges, offers intriguing prospects in the healthcare sector. With its roots..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds